• By Jennifer O'Hara

Mayo Clinic Q&A podcast: Convalescent plasma program

May 21, 2020
a specimen box in a laboratory of several bags of plasma for COVID-19 research

In response to the COVID-19 pandemic, the U.S. Government is supporting a national Expanded Access Program to collect and provide convalescent plasma to patients in need across the country (uscovidplasma.org). Convalescent plasma refers to blood plasma collected from people who have recovered from COVID-19. That plasma, which contains antibodies against the virus, is then used to treat others with advanced illness. Working collaboratively with industry, academic and government partners, Mayo Clinic is serving as the lead institution for the program.

On the Mayo Clinic Q&A podcast, Dr. Philippe Bauer, site principal investigator for Mayo Clinic in Rochester, discusses the COVID-19 convalescent plasma program.

Mayo Clinic Q&A is available on podcast platforms including AppleGoogleSpotifyStitcherTuneIn and iHeart


Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding along with guidelines and recommendations may have changed since the original publication date

Check the Centers for Disease Control and Prevention website for additional updates on COVID-19. For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.

Please login or register to post a reply.